Initially, 24 subjects enrolled in the study. However, one subject dropped out due to training conflicts with his sport. The other 5 subjects withdrew of their own volition due to an inability to tolerate the physical demands of the testing protocol. This study was limited to males in order to control for fluctuations in cortisol that occur during the menstrual cycle. Risks PF-562271 in vivo and benefits
were explained to the subjects and each of them gave written informed consent prior to participation in the study. At initial enrollment, all subjects self-reported to be free from current injuries limiting their ability to train and complete physiological testing. Additionally, all subjects were asked to refrain from using
anti-inflammatory medication or drinking tea during the course of the study. Subjects were asked about supplement use within the past 6 months. Those subjects on supplements were directed to continue to use the supplement at the current dosage throughout the entire study provided they had been consuming the supplement for at least one month prior. If they had not been using the supplement for at least one month, they discontinued the use of the supplement and completed a 2-week washout phase prior to commencing with the study. Each subject was screened by a member of the research team prior to commencing with each day of testing in order to assess compliance to supplementation and adherence to the exclusion criteria. Prior to enrollment in the study, a health screening was also completed with each subject in accordance with American College of Sports Medicine (ACSM) exercise testing Selleckchem LB-100 procedures. Study Design and Supplementation A double-blind, crossover design was used for this study. Each subject completed a familiarization session to control for practice effects on the anaerobic test
[20] and two separate testing sessions (T1 and T2). During T1 and T2, participants had body Galeterone composition PF-4708671 mouse assessed and blood samples were obtained before, immediately after, 30- and 60-min after a Wingate Anaerobic Test (WAnT) for later analysis of oxidative stress markers (8-iso PGF2α [8-isoprostane], total and oxidized glutathione [GSH and GSSG]), cortisol (CORT), and inflammatory cytokine (interleukin 6 [IL-6]). Additionally, capillary blood samples were analyzed during each test in order to assess blood lactate accumulation and recovery. Participants were asked to rate perceived muscle soreness at 24 and 48 h post on a visual analog scale. Subjects were required to refrain from training for 24 h prior to each test and to refrain from lower body training for at least 24 h post. Additionally, each subject was tested at the same time of day for each test to control for diurnal variations. Participants were instructed to continue with their normal exercise training during the study.